Scarica l'app Stockscreener
255.04
9.09%
-25.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption - MSN
Bio-Rad Laboratories Q1 2026 Earnings Call Transcript - MarketBeat
Bio-Rad Laboratories Inc (BIO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
Bio-Rad Laboratories Q1 Earnings Call Highlights - Yahoo Finance
BIO SWOT Analysis: Financial Challenges and Growth Potential Rev - GuruFocus
Bio-Rad's Timing for Revenue Growth Recovery Remains Uncertain - Morningstar
MSN Money - MSN
Bio-Rad (BIO) Reports Strong Q1 Revenue Amidst Market Challenges - GuruFocus
Bio-Rad Q1 2026 slides: earnings beat masks currency headwinds - Investing.com
Bio-Rad Laboratories (BIO) Lags Q1 Earnings Estimates - Yahoo Finance
Bio-Rad (BIO) Q1 2026: Non-GAAP EPS $1.89 (miss vs $2.81), Reven - GuruFocus
Bio-Rad Laboratories Reports Q1 2026 Results, Cuts Outlook - TipRanks
Transcript: Bio-Rad Laboratories Q1 2026 Earnings Conference Call - Benzinga
Bio-Rad Laboratories (BIO) Releases Q1 2026 Earnings: Revenue Up Slightly, EPS Deeply Negative on Large GAAP Loss - Quiver Quantitative
Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises - marketscreener.com
Bio-Rad: Q1 Earnings Snapshot - KTVB
Liquidity Mapping Around (BIO) Price Events - Stock Traders Daily
Huge Sartorius loss drives Bio-Rad (NYSE: BIO) Q1 2026 net loss - Stock Titan
Bio-Rad (NYSE: BIO) posts Q1 loss and trims 2026 guidance - Stock Titan
Bio-Rad Reports First-Quarter 2026 Financial Results - Business Wire
Bio-Rad earnings on deck: Can margin recovery offset academic headwinds? - Investing.com Australia
Bio-Rad earnings on deck: Can margins recover after rough 2025? - Investing.com Canada
Food Diagnostics Market to Reach USD 32.8 Billion by 2033 at 9.0% - openPR.com
Transcriptomics Technologies Market to Reach USD 20.64 Billion - openPR.com
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers - News-Medical
Bio-Rad (NYSE: BIO) CFO nets more shares after RSU vesting and tax withholding - Stock Titan
Bio-Rad (BIO) EVP Courtney Enloe gains shares via RSU vesting, withholds for taxes - Stock Titan
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report - GlobeNewswire
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux - Yahoo Finance
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential - DirectorsTalk Interviews
Citigroup downgrades Bio-Rad Laboratories (BIO) - MSN
Bio-Rad Laboratories, Inc. Amends 2017 Incentive Award Plan and Updates Entity Information in April 2026 8-K Filing - Minichart
Bio-Rad Laboratories (BIO.US) will release its earnings report after the market closes on April 30. - Moomoo
Bio-Rad Laboratories Stockholders Approve Directors and Governance Items - TipRanks
Shareholders of Bio-Rad (NYSE: BIO) approve 2017 incentive plan changes - Stock Titan
Bio-Rad Laboratories, Inc. (BIO) PT Reduced to $300 by Citigroup Amid Process Chromatography Concerns - Yahoo Finance
Bio-Rad Laboratories Inc (BIO) Shares Fall 6.4% -- What GF Score of 77 Tells Investors - GuruFocus
Greg K. Hinckley adds Bio-Rad (BIO) shares through RSU vesting and grant - Stock Titan
Bio-Rad (NYSE: BIO) director exercises 407 RSUs and receives 369-unit grant - Stock Titan
Bio-Rad (NYSE: BIO) director exercises 407 RSUs and gains 369 new units - Stock Titan
Bio-Rad (BIO) director Arnold Pinkston gains shares, receives new RSU grant - Stock Titan
9 Most Undervalued Healthcare Stocks to Buy Now - Insider Monkey
Electroporation Instruments Market is expected to Hit US$ - openPR.com
Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday - MarketBeat
Boston Trust Walden Corp Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpHere's Why - MarketBeat
DNA Extraction, Isolation and Purification Market: Key Players - openPR.com
Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com
Digital PCR Market Set for Strong Growth to US$ 1.45 Billion - openPR.com
Cell Identification Technology Market Is Going to Boom Rapidly | - openPR.com
dPCR Market Will Generate Booming Growth Opportunities to 2031 | - openPR.com
Research Antibodies Market to Reach USD 2,307.59 Billion by 2033 - openPR.com
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a Healthcare Giant with a 1.16% Upside Potential - DirectorsTalk Interviews
Why (BIO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Is Bio-Rad Laboratories Stock Worth Watching Right Now - Kalkine Media
Press Release: Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 - 富途牛牛
Bio-Rad Laboratories, Inc. $BIO Shares Bought by Assetmark Inc. - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Update - MarketBeat
Ion Chromatography Analyzer Market Size Accelerating at 7.9% - openPR.com
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 - Business Wire
Araceli Biosciences Adds Former Bio-Rad CFO Tsingos to Board to Support Scaling Push - TipRanks
Araceli Biosciences Appoints Christine Tsingos to Board of Directors - The AI Journal
Real Time PCR and Digital PCR Market Size Accelerating at 9.8% - openPR.com
Bio-Rad extends range of Anti-Idiotypic Antibodies and Anti-Fc Mutation Antibodies - SelectScience
Bio-Rad (BIO) Surged as the Earnings Exceeded Expectations - MSN
Neuroscience Antibodies and Assays Market to Reach USD 11.35 - openPR.com
Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring - News-Medical
0.64%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):